QualityStocks Stock Newsletters Archives - Page 407 of 1818

WednesdaySep 22, 2010 3:01 pm

Pioneer Behavioral Health (PHC) Reports Strong Fourth Quarter

Pioneer Behavioral Health reported a strong year over year increase in sales in the fourth quarter of fiscal 2010 as the company continues its recovery from the recession of 2009. The company also reported a profit compared to a loss in the same period a year earlier. Pioneer Behavioral Health reported net sales of $14 million in the quarter ending 6/30/2010, compared to $11.7 million in the fourth quarter of fiscal 2009. The company attributed the large gain to increased occupancy at the Seven Hills Behavioral Institute, the Detroit Behavioral Institute and Harbor Oaks Hospital. Pioneer Behavioral Health reported net…

WednesdaySep 22, 2010 2:02 pm

Greenlight Resources Inc. (PRZCF) Provides Update on Lithium Project in Canada

Greenlight Resources Inc. issued an update on the development program at its properties in Canada, where the company is conducting phase one testing of the mineral potential of the area. Greenlight Resources Inc. has interests in the Brazil Lake Lithium and Rare Metal property located north of Yarmouth, Nova Scotia. The company has drilled a total of fourteen cored holes in order to assess the mineral component of its property. The total core sample length obtained to date is 1,829 meters with another 400 meters left in phase one. Greenlight Resources Inc. is looking for lithium deposits of sufficient size…

WednesdaySep 22, 2010 2:00 pm

RXi Pharmaceuticals Corp. (RXII) Partners with EyeGate to Advance Ocular Treatment Technology

RXi Pharmaceuticals Corp. has developed a comprehensive therapeutic platform based on RNA interference (RNAi) therapeutics to treat a number of diseases, scarring and retinal disorders. The company today announced its partnership with EyeGate Pharma, a leader in non-invasive ocular drug delivery, to collaborate on the ocular delivery of RNAi therapeutics. Per the agreement, both companies will contribute technology, expertise, and resources to develop ocular treatments. "The development of RNAi therapeutics to treat retinal disorders is a key focus for our company, and we are excited to be collaborating with EyeGate to explore new, patient friendly approaches for delivering RNAi therapeutics…

WednesdaySep 22, 2010 11:30 am

Curaxis Pharmaceutical Corp. (CURX.OB) Enters Into Equity Line Agreement with Southridge Partners

Curaxis Pharmaceutical Corp. is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and also multiple cancers. The company's therapeutic platform is based on the hypothesis that many diseases of aging may be caused by age-related changes in the function of a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. The premise is that hormones associated with the feedback loop are beneficial early in life when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised. Curaxis announced today that…

WednesdaySep 22, 2010 11:28 am

Protectus Medical Devices, Inc. (PTMD.PK) Obtains U.S. Patent for Self-Sheathing Safety Syringe

Protectus Medical Devices, Inc. is proving to be a company on the move. Located in Minneapolis, Minnesota, Protectus, formerly known as E-18 Corp., operates through its wholly-owned subsidiary SquareOne Medical which develops and markets innovative safety medical devices that have the potential to drastically reduce needlestick injuries for medical professionals across the globe. Today, Protectus Medical took a major step towards prominence with the announcement they have received a U.S. Patent for its self-sheathing safety syringe. The patent which was granted by the U.S. Patent and Trademark Office is No. 7,799,002. This patent will provide 20 years of patent protection…

WednesdaySep 22, 2010 10:16 am

Alpha Pro Tech Ltd. (APT) Video Chart for Wednesday, September 22, 2010

The APT chart has continued to create bottoms and slip through. However, over the past couple months, it has established a new base and made higher lows. It is now on radar as it attempts to step up to the next level. Please click the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

WednesdaySep 22, 2010 9:18 am

Axion International (AXIH.OB) Adds to Their Board of Directors

Axion International announced yesterday that Perry Jacobson, Managing Director at Brookstone Partners, and Michael Dodd, CEO of 3D Global Solutions, were elected to Axion’s Board of Directors. After several years of valuable service, Axion Board member, Lori Jones, has resigned from Axion’s Board. The Company stated that they wish her success and appreciate her contribution. Jim Kerstein, Axion CEO and Co-founder, stated, “Perry and Mike are going to be tremendous assets to Axion as we continue to grow the company. Perry’s insights and experience in the capital markets and Mike’s experience in management consulting and working with Military purchasing will…

TuesdaySep 21, 2010 2:30 pm

Interleukin Genetics, Inc. (ILIU.QB) Details Findings of Huge Osteoarthritis Study

Interleukin Genetics, www.ilgenetics.com – developer of the Inherent Health® brand of genetic test systems like the proprietary PST® genetic risk panel for periodontal disease and susceptibility to tooth loss and the Weight Management Genetic Test for determining ideal exercise/diet based on personal genetics, announced exciting Osteoarthritis (OA) findings today in conjunction with the Thurston Arthritis Research Center at the University of North Carolina at Chapel Hill. Data from the large clinical study, which was aimed at quantifying the role genetic factors play in the progression of osteoarthritis, indicates a nearly doubled propensity for the disease to progress to a “severe”…

TuesdaySep 21, 2010 2:24 pm

Aethlon Medical, Inc. (AEMD.OB) Poised to Capitalize on Strategic Biodefense Initiatives

Aethlon Medical, www.aethlonmedical.com – a leading pioneer in the development of sophisticated therapeutic filtration technology for the prevention or amelioration of infectious diseases, including cancer (by removing immunosuppressive agents), reported today the reestablishment of concerted efforts to advance the Aethlon Hemopurifier® as a bioterrorism countermeasure within applicable US governmental programs. The capacity of this revolutionary technology, to selectively target and remove from the circulatory system infectious viruses and immunosuppressive proteins, represents the most advanced and perhaps only truly broad-spectrum countermeasures for weaponized viruses. The Hemopurifier is a very attractive candidate to entities like U.S. Health and Human Services Department (HHS),…

TuesdaySep 21, 2010 2:18 pm

Leeward Group Holdings, Inc. (PCPZ.OB) Initiates Push Into Life and Health Insurance

Leeward Group Holdings Inc., through its wholly-owned subsidiaries, operates a full-service insurance agency and consulting firm. The company serves businesses and individuals through its five retail locations. Leeward has three offices in New England and two offices in the mid-Atlantic region. In addition, with licenses in all 50 states, the company can offer property & casualty, life & health, along with specialty insurance to customers all over the country. The company announced today that it is initiating a marketing push into life and health insurance. Leeward Group has an agency foundation for property and casualty insurance that will serve as…

Site Search

Company Search

Category: QualityStocks Stock Newsletters